CMMB

Chemomab Therapeutics Ltd

• Reuters·03/31 20:06

  Chemomab files Form 3 for director Jill Quigley’s beneficial ownership statement

• TipRanks·03/22 14:20

  Analysts Offer Insights on Healthcare Companies: Knight Therapeutics (OtherKHTRF) and Chemomab Therapeutics (CMMB)

• TipRanks·03/20 20:27

  Chemomab Therapeutics Sets April 28, 2026 Shareholder Meeting to Vote on Capital Increase and Governance Matters

• TipRanks·03/20 13:35

  Maxim Group Remains a Buy on Chemomab Therapeutics (CMMB)

• Seeking Alpha·03/19 18:39

  Chemomab Therapeutics reports Q4 results

• TipRanks·03/19 12:37

  Chemomab Sets Single-Phase 3 Path With FDA After Strong 2025 Nebokitug Data

• Benzinga·03/19 12:27

  Chemomab Therapeutics Q4 EPS $(0.24) Beats $(0.40) Estimate

• TipRanks·03/19 12:11

  Chemomab Therapeutics sees cash runway through 1Q27

• Reuters·03/19 12:09

  Israel's Chemomab Q4 net loss narrows on lower R&D spend

• TipRanks·03/19 12:05

  Chemomab Therapeutics reports FY25 EPS (1c) vs. (4c) last year

• Reuters·03/19 12:04

  Chemomab FY 2025 net loss fell 35.5% to USD 9 million

• Reuters·03/19 12:00

  CHEMOMAB THERAPEUTICS: EVALUATING ADDITIONAL THERAPEUTIC INDICATIONS WHERE NEBOKITUG HAS GENERATED ROBUST PRECLINICAL EFFICACY SIGNALS

• Reuters·03/19 12:00

  CHEMOMAB THERAPEUTICS Q4 OPERATING EXPENSES USD 1.974 MILLION

• TipRanks·03/06 13:20

  Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP), Chemomab Therapeutics (CMMB) and Reviva Pharmaceuticals Holdings (RVPH)

• TipRanks·12/23/2025 13:25

  Maxim Group Keeps Their Buy Rating on Chemomab Therapeutics (CMMB)